Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	700-800
Total Number of Projects:	400-500
2019
Criterium:	Position:
Overall Score:	400-500
Total Number of Projects:	200-300
2018
Criterium:	Position:
Overall Score:	800-900
Total Number of Projects:	300-400
Networking Rank (Reputation):	> 1000
2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2023-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 50
As coordinator: 0
As participant: 50
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	3.260.000	0		1
2021	0	87.544.485	0		10
2020	0	134.831.192	0		9
2019	0	196.939.080	0		13
2018	0	103.838.674	0		7
2017	0	66.023.667	0		8
2016	0	14.080.000	0		2

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
NOVARTIS PHARMA	31
JANSSEN PHARMACEUTICA NV	24
SANOFIAVENTIS	24
BAYER	21
F HOFFMANNLA ROCHE	18
UCB BIOPHARMA	18
NOVO NORDISK	15
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	15
ASTRAZENECA	14
KATHOLIEKE UNIVERSITEIT LEUVEN	14
TAKEDA PHARMACEUTICALS INTERNATIONAL	14
ABBVIE INC	13
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	13
ELI LILLY AND COMPANY LIMITED	12
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	11
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	11
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	10
TAKEDA DEVELOPMENT CENTRE EUROPE	10
CHARITE UNIVERSITAETSMEDIZIN BERLIN	9
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	9
UNIVERSITY OF NEWCASTLE UPON TYNE	9
FORUM DES PATIENTS EUROPEENS	8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	8
MERCK SHARP & DOHME CORP	8
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	7
KAROLINSKA INSTITUTE	7
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	7
MEDIZINISCHE UNIVERSITAET WIEN	7
THE UNIVERSITY OF MANCHESTER	7
UNIVERSITY OF DUNDEE	7
UPPSALA UNIVERSITET	7
ACADEMISCH ZIEKENHUIS GRONINGEN	6
LEIDS UNIVERSITAIR MEDISCH CENTRUM	6
STICHTING VUMC	6
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	6
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA	6
THE UNIVERSITY OF LIVERPOOL	6
UNIVERSITY COLLEGE DUBLIN	6
UNIVERSITY COLLEGE LONDON	6
UNIVERSITY OF CAMBRIDGE	6
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE	5
GLAXOSMITHKLINE BIOLOGICALS	5
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS	5
INSTITUT DE RECHERCHES SERVIER	5
KING'S COLLEGE LONDON	5
SERVICIO MADRILENO DE SALUD	5
STICHTING KATHOLIEKE UNIVERSITEIT	5
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	5
UNIVERSITAT WIEN	5
UNIVERSITATSKLINIKUM ERLANGEN	5
VIB VZW	5
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
ASTELLAS PHARMA EUROPE BV	4
ASTRAZENECA AB	4
BRISTOLMYERS SQUIBB COMPANY CORP	4
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	4
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	4
ELI LILLY AND COMPANY	4
EUROPEAN CANCER PATIENT COALITION	4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE	4
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION	4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	4
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA	4
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE	4
LUND UNIVERSITY	4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	4
OSPEDALE PEDIATRICO BAMBINO GESU	4
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	4
SERVICIO ANDALUZ DE SALUD	4
TARTU ULIKOOL	4
TEAM IT RESEARCH SL	4
THE UNIVERSITY OF EDINBURGH	4
THE UNIVERSITY OF SHEFFIELD	4
TTOPSTART BV	4
UNIVERSITA CATTOLICA DEL SACRO CUORE	4
UNIVERSITA VITASALUTE SAN RAFFAELE	4
UNIVERSITAET BERN	4
UNIVERSITY OF BIRMINGHAM	4
UNIVERSITY OF BOLOGNA	4
UNIVERSITY OF COPENHAGEN	4
UNIVERSITY OF GLASGOW	4
ACADEMISCH ZIEKENHUIS LEIDEN	3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS	3
ALLERGAN LIMITED	3
AMGEN LIMITED	3
ANTAROS MEDICAL AB	3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	3
AUSTRIAN RESEARCH CENTERS SIEBERDORF	3
CELGENE MANAGEMENT SARL	3
COMMISSARIAT A L'ENERGIE ATOMIQUE	3
EBERHARD KARLS UNIVERSITAET TUEBINGEN	3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	3
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH	3
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL	3
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES	3
FUJIFILM CELLULAR DYNAMICS INC	3
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA	3
FUNDACIO SANT JOAN DE DEU	3
GRUNENTHAL	3

Constancy:

Total number of partners: 1455
Partner loyalty:
Frequent Partner: (> 2 projects): 749
Rare Partner: 706
Frequent / Rare Partner Ratio: 1.06

Project overview:

Start date	Project	acronym	role	funding	partners
2022-01-01	FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem	FACILITATE	participant	3.260.000	29
2021-11-01	Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance	PrIMAVeRa	participant	6.500.000	19
2021-11-01	Preparing for RSV Immunisation and Surveillance in Europe	PROMISE	participant	3.744.375	22
2021-10-01	Optimal treatment for patients with solid tumours in Europe through Artificial intelligence	OPTIMA	participant	10.459.997	39
2021-10-01	Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies	SCREEN4CARE	participant	11.938.569	37
2021-09-01	BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe	BEAMER	participant	5.948.903	31
2021-07-01	Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States	HIPPOCRATES	participant	10.210.993	27
2021-07-01	Real World Handling of Protein Drugs - Exploration, Evaluation and Education	RealHOPE	participant	3.139.984	27
2021-06-01	Add medical genetic solutions to RESOLUTE (REsolution)	REsolution	participant	1.000.000	9
2021-02-01	Central Repository for Digital Pathology	BIGPICTURE	participant	32.319.825	51
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-11-01	Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment	Gravitate-Health	participant	9.280.000	42
2020-11-01	Accelerating Research & Development for Advanced Therapies	ARDAT	participant	11.773.000	34
2020-10-01	H2O Health Outcomes Observatory	H2O	participant	10.476.687	25
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	41
2020-06-01	Stratification of Obesity Phenotypes to Optimize Future Therapy	SOPHIA	participant	8.301.000	36
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	23
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2020-01-01	Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	ImmUniverse	participant	15.500.000	28
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	30
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	47
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	37
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	participant	15.000.000	23
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	35
2019-03-01	EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells	EBiSC2	participant	4.599.648	18
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-02-01	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease	TransBioLine	participant	13.999.998	29
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2019-01-01	Vaccines and Infectious Diseases in the Ageing PopuLation	VITAL	participant	5.499.882	24
2018-11-01	European Health Data and Evidence Network	EHDEN	participant	14.105.750	22
2018-09-01	WEB-RADR 2	WEB-RADR 2	participant	1.168.750	12
2018-09-01	Ensuring the future of EUPATI beyond 2020	EFOEUPATI	participant	365.243	12
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2018-05-01	Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production	iConsensus	participant	4.700.000	19
2018-05-01	conect4children (COllaborative Network for European Clinical Trials For Children)	c4c	participant	67.000.000	47
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	35
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-11-01	Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections	COMBACTE-CDI	participant	2.312.305	14
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Rheuma Tolerance for Cure	RTCure	participant	6.000.000	20
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064	ITCC-P4	participant	7.370.000	21
2017-01-01	Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106	IB4SD-TRISTAN	participant	12.000.000	21
2017-01-01	REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019	RESCEU	participant	14.498.125	18
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-04-01	Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916	PRISM	participant	8.080.000	23

PFIZER LIMITED - United Kingdom